Congressional News
COSSA Releases Analysis of Senate Draft FY 2023 Appropriations Bills
In late July, the Senate Appropriations Committee released drafts of its fiscal year (FY) 2023 appropriations bills. As previously reported, the House introduced its bills in June and passed half of them in July. While the Senate Appropriations Committee is not planning to take up the bills individually through the regular committee process, the release of its bills allows House and Senate appropriators to begin talks and, hopefully, work toward an agreement on final FY 2023 spending in the fall. Across many of the accounts, the Senate bills seek sizable increases for federal science agencies and programs, in many cases,…
COSSA Analyzes Recently Passed CHIPS and Science Act
As previously reported, Congress passed sweeping innovation legislation in late July that promises to make major new investments in the U.S. scientific enterprise and bolster American leadership in cutting-edge research and technology. The Chips and Science Act of 2022 was signed into law by President Biden on August 9 in a ceremony on the South Lawn of the White House that included Members of Congress, heads of federal science agencies, technology industry CEOs, and representatives of the scientific community. COSSA Executive Director Wendy Naus had the honor of attending the signing on behalf of the social and behavioral science community….
Sweeping Innovation Bill Crosses the Finish Line
Before recessing for the remainder of summer, Congress passed the CHIPS and Science Act (H.R. 4346) in late July. This collection of bills has taken many forms over the last two years and has gone by many different names, including the Endless Frontier Act, America COMPETES Act, and U.S. Innovation and Competition Act). The final version gained traction over the last few months following significant disruption to the global microelectronics supply chain resulting from the ongoing pandemic. These concerns reinvigorated Congressional interest in innovation and competitiveness legislation, which led to the CHIPS and Science Act that also incorporates ambitious funding…
Senate Appropriations Committee Releases FY 2023 Bills
On July 28, the Senate Appropriations Committee released its fiscal year (FY) 2023 appropriations bills. As previously reported, the House introduced its bills in June and passed half of them in late July. While the Senate Appropriations Committee is not planning to take up the bills through the regular committee process, the release of the Senate bills allows House and Senate appropriators to begin talks and, hopefully, work toward an agreement on final FY 2023 spending in the fall. Below is a comparison of the House-passed and draft Senate bills for science agencies: COSSA will issue a full analysis of…
NSF and Congressional Women in STEM Caucus Hold Joint Briefing
On July 28, the National Science Foundation (NSF) and Congressional Women in STEM Caucus held a joint briefing, “Meeting Today’s Moment: A panel discussion with women leading the way on scientific innovations.” Panelists included Chief Operating Officer of NSF Karen Marrongelle, Professor and Endowed Chair of Chemistry and Biochemistry at the University of California at San Diego Rommie Amaro, Professor of Astronomy and Physics and College of Science Associate Dean for Research at the University of Arizona Feryal Özel, and Associate Professor of Physics and Director of the Institute for Gravitation and the Cosmos at Pennsylvania State University Sarah Shandera. …
COSSA Releases Analysis of FY 2023 House Appropriations Bills
Over the last few weeks, the House Appropriations Committee began considering its annual spending bills for fiscal year (FY) 2023, including the bills that fund federal science, research, and data activities. In some cases, the House proposals mirror priorities laid out in the President’s FY 2023 budget request. However, in most cases, funding allocations did not allow House appropriators to include the sizeable increases sought by the Biden Administration. Still, achieving increases in a funding environment that continues to be impacted by a global pandemic is an important feat. Lawmakers have just three more weeks of work in July before…
Congress Gets Moving on FY 2023 Appropriations Bills
Last week, half of the subcommittees of the House Appropriations Committee marked up their respective spending bills for fiscal year (FY) 2023; the remaining bills—including those of particular interest to the research community—are scheduled for consideration this week. In the next couple of days, the House Commerce, Justice, Science and the House Labor, Health and Human Services, Education Subcommittees will consider their respective bills. The full House Appropriations Committee is expected to take up the bills individually in the coming weeks with a goal of bringing as many to the House floor as possible before the August month-long recess. Despite…
Busy June Ahead for Lawmakers
Congress returns from Memorial Day recess with renewed pressure to enact legislation to stem gun violence in the United States following the most recent mass shootings over the last few weeks. House leaders have promised a vote on one such package (H.R. 7910) later this week; however, the Senate requires a super majority (60 votes) in order to pass such a bill, making the bill a much bigger lift. In addition, as previously reported, Congress is also steeped in the annual appropriations process for fiscal year (FY) 2023. While earlier in the year it was hinted that markups on the…
House Committee Marks Up ARPA-H Authorization Legislation, Advances to House Floor
On May 18, the House Energy and Commerce (E&C) Committee marked up several pieces of legislation including the Advanced Research Project Agency for Health (ARPA-H) Act (H.R. 5585), authorization legislation for the newly established health research agency. During the markup, the bill championed by the E&C Health Subcommittee Chair Anna Eshoo (D-CA) was amended to explicitly state that ARPA-H would be established as an “independent operating division within the Department of Health and Human Services” and directs the Biden Administration to transfer ARPA-H away from the National Institutes of Health (NIH), pushing back on the Administration’s recent move to house…
Congress Holds FY 2023 Budget Hearings for NIH
Over the past few weeks, the House and the Senate held their respective budget hearings for the National Institutes of Health (NIH) for fiscal year (FY) 2023, hearings that typically feature the NIH director and several of the directors of NIH’s institutes and centers (ICs). On May 11, the House Appropriations Subcommittee on Labor, Health and Human Services, Education, and Related Agencies (LHHS) held its hearing led by Full Committee Chairwoman Rosa DeLauro (D-CT) and Subcommittee Ranking Member Tom Cole (R-OK). Witnesses included Acting Director of NIH Larry Tabak, Director of the National Institutes of Child Health and Human Development…
Congress Returns from Recess, Gets Moving on FY 2023 Budget Oversight
Congress returns this week from its two-week recess to a packed agenda. Oversight hearings on the President’s fiscal year (FY) 2023 budget request have begun in earnest, with Biden Administration officials appearing before House and Senate Committees throughout the week to defend the President’s funding priorities for next year. Reports indicate an ambitious timeline in the House for considering the FY 2023 appropriations bills. It has been reported that House leadership is looking to hold floor votes on as many FY 2023 bills as possible in July, meaning the House Appropriations Committee and various subcommittees will need to complete their…
Congress Continues to Hint at Upcoming Mental Health Package
On April 5, the House Energy and Commerce Subcommittee on Health met to discuss legislation to support American mental health and well-being. The hearing, overseen by Subcommittee Chair Anna Eshoo (D-CA) and Ranking Member Brett Guthrie (R-KY), is one of many Congressional hearings held in the past few months focused on potential policy solutions related to mental health (see previous coverage for more details). The hearing included two panels of experts. The first panel featured Assistant Secretary for Mental Health and Substance Use at the Substance Abuse and Mental Health Services Administration (SAMHSA), Dr. Miriam E. Delphin-Rittmon, and Administrator at…
Senate Discusses Substance Use and Mental Health Disorders, Hints at Bipartisan Legislation
On March 23, the Senate Health, Education, Labor and Pensions Committee held a hearing to discuss the national mental health and substance use disorder crisis and the federal programs being used to address these issues. The hearing, overseen by Committee Chair Patty Murray (D-WA) and Ranking Member Richard Burr (R-NC), is one of many Congressional hearings held in the past few months focused on potential policy solutions related to mental health (see previous coverage for more details). The witnesses present at the hearing were Assistant Secretary for Mental Health and Substance Use at the Substance Abuse and Mental Health Services…
Congress Finally Agrees on FY 2022 Funding, Mixed Bag for Science
Nearly six months into the new fiscal year, Congress has finally completed its work on the fiscal year (FY) 2022 appropriations bills, securing funding for federal departments, agencies, and programs through September 30, 2022. After months of stalemate and rocky negotiations, House and Senate leaders agreed to an overall FY 2022 framework that includes roughly equal increases to defense and non-defense funding, delivering a major win to Republicans who were pushing for parity throughout the process. The eleventh hour increase in defense spending in the final package resulted in smaller-than-expected increases to nearly all agencies and programs important to the…
Science Funding, Aid to Ukraine, and a Supreme Court Nomination
Congress will have its hands full over the coming weeks as lawmakers attempt to finish up fiscal year (FY) 2022 appropriations bills while also seeking emergency aid to Ukraine. Senators will have an especially busy schedule as they begin consideration of Supreme Court nominee Ketanji Brown Jackson. We are likely to see attempts to provide funding for Ukraine as part of a package that will also include the FY 2022 bills. As previously reported, Congress has until March 11 to complete the appropriations for the fiscal year that is nearly half over. The next few weeks will be critical for…
Congress Continues Focus on Mental Health in Subcommittee Hearing
On February 17, the House Energy and Commerce Oversight Subcommittee held a hearing to discuss the national mental health crisis and plans to address it. The hearing, overseen by Subcommittee Chair Diana DeGette (D-CO) and Ranking Member Morgan Griffith (R-VA), is the third Congressional hearing in the past month focused on potential policy solutions related to mental health (see previous coverage for more details). The witnesses present at the hearing were American Psychiatric Association member and vice-chair of psychiatry at the University of California, San Francisco Dr. Lisa Fortuna, assistant professor of psychiatry and human behavior at Brown University Dr….
FY 2022 Funding to be Delayed Until March 11
Congress has yet to enact final fiscal year (FY) 2022 funding legislation almost five months into the fiscal year. The federal government has been operating under a continuing resolution (CR) since October 1, 2021, which is set to expire this Friday, February 18. Last week, House and Senate leaders announced they had come to agreement on a framework that would allow lawmakers to complete work on the overdue annual spending bills. A new stopgap funding measure was passed by the House last week giving lawmakers until March 11 to complete their work. The Senate is seeking to pass the extension…
House Subcommittee Weighs Arguments for an Independent ARPA-H
On February 8, the Subcommittee for Health within the House Committee on Energy and Commerce (E&C) held a hearing on the proposed Advanced Research Projects Agency for Health (ARPA-H) with a heavy focus of the discussion on the structure of the agency within the federal government. Among other issues, members of the Committee heard testimony on whether a DARPA-like research agency should be housed within the National Institutes of Health (NIH) as proposed by the Biden Administration or established as an independent agency under the Department of Health and Human Services (HHS). Witnesses included Vice Chancellor for Science Policy and…